國家衛生研究院 NHRI:Item 3990099045/13917

NHRI > National Institute of Cancer Research > Nai-Jung Chiang > Conference Papers/Meeting Abstract > Item 3990099045/13917

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/13917

Title:	An integrated microfluidic platform for cholangiocarcinoma diagnosis from clinical bile juice samples by utilizing multiple affinity reagents
Authors:	Lu, TH;Chiang, NJ;Huang, CJ;Gopinathan, P;Tu, HC;Tsai, YC;Shan, YS;Hung, SC;Lee, GB
Contributors:	National Institute of Cancer Research
Abstract:	Cholangiocarcinoma (CCA) is a lethal disease owing to its difficulty to be diagnosed at early stages and lack of effective treatment. To improve the accuracy of early diagnosis of CCA, one of the promising approaches is to use CCA-specitic affinity reagents to detect CCA cells by liquid biopsy. In this study, bile juice, a body fluid close to lesions, was used as a clinical sample for CCA cell isolation and detection. Moreover, a novel microfluidic chip was designed and fabricated to detect CCA cells in the bile juice by using three types of affinity reagents. Experimental results showed that the three affinity reagents could capture CCA tumor cells in patients' bile juice (with a volume of only 3 mL) within 120 min. This microfluidic system may serve as a promising tool for detecting CCA in clinical settings.
Date:	2020-11
Relation:	2020 IEEE 15th International Conference on Nano/Micro Engineered and Molecular System (IEEE Nems 2020). 2020 Nov:261-264.
Link to:	http://dx.doi.org/10.1109/NEMS50311.2020.9265566
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000722588100044
Appears in Collections:	[Nai-Jung Chiang] Conference Papers/Meeting Abstract

Files in This Item:

File	Description	Size	Format
ISI000722588100044.pdf		767Kb	Adobe PDF	139	View/Open